Cerevel Therapeutics logo

Cerevel Therapeutics

We are a biopharmaceutical company focused on unraveling the mysteries of the brain to treat neuroscience diseases.

373 employees · est. 2018 · Cambridge, United States

VS
Graviton Bioscience logo

Graviton Bioscience

Curing Disease through Restored Homeostasis

32 employees · est. 2023 · New York, United States

Cerevel Therapeutics is the older company (2018 vs 2023); Cerevel Therapeutics is the larger of the two.

Side-by-Side Comparison

Cerevel Therapeutics Graviton Bioscience
Founded
2018 older 2023
Headquarters
Cambridge, United States New York, United States
Employees
373 larger 32
Industry
Biotechnology, Health and Wellness, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
Post Ipo Equity Private Equity
Total Funding
$1.90B $64.82M
Funding Rounds
6 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Neuroscience, CNS Disorders, Clinical-stage Compounds, Pre-clinical Compounds, Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Schizophrenia, Addiction, Bain Capital, Pfizer, Neurocircuitry, Receptor Selectivity, Pipeline Clinical-stage, Drug Discovery, CNS Disorders, Autoimmune Disorders, Fibrotic Disorders, ROCK2 Inhibition, Therapeutic Compounds, Homeostasis Restoration, Disease Treatment, Pharmaceuticals
Website
cerevel.com gravitoncorp.com
Cerevel Therapeutics logo

About Cerevel Therapeutics

Cerevel Therapeutics is a biopharmaceutical company founded in 2018 and headquartered in the Greater Boston area, United States. The company is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. Cerevel Therapeutics focuses on developing new therapies for disorders of...

Graviton Bioscience logo

About Graviton Bioscience

Graviton Bioscience is a biotechnology startup that aims to cure diseases through restored homeostasis. Founded in 2023 and headquartered in the United States, their focus lies in developing therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), in addition to oth...

We will tell you when either one moves

BounceWatch watches Cerevel Therapeutics and Graviton Bioscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cerevel Therapeutics and Graviton Bioscience — by email.

Frequently Asked Questions

Cerevel Therapeutics — We are a biopharmaceutical company focused on unraveling the mysteries of the brain to treat neuroscience diseases.. Graviton Bioscience — Curing Disease through Restored Homeostasis. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cerevel Therapeutics has raised $1.90B while Graviton Bioscience has raised $64.82M.
Cerevel Therapeutics and Graviton Bioscience operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cerevel Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Cerevel Therapeutics on 26 Jul 2024, and Graviton Bioscience on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes